Stock · CNC · Healthcare
United States · Large Cap · listed since 2001 · Revenue 12 mo. $193.7B
Price as of 11/06/2026
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States.
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Original text from the data provider
Summary
46.0 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
Required FCF growth per year
no growth
no growth afterwards
Price to operating cash flow 3.6×, below its usual range.
Middle half of 20 quarters: 4.3× to 12.1×, median 6.5×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
Since the last quarter
Q1 → Q2 2026
3 more unchanged: Revenue, 12 mo., EBIT margin, Shares outstanding
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | −33.44% | 11.52% | Rank 6 |
| Return on capital (Greenblatt) | −45.16% | 32.55% | Rank 4 |
| EBIT margin | −3.91% | 18.31% | Rank 5 |
| FCF margin | 2.22% | 14.12% | Rank 13 |
| Gross margin | 12.24% | 60.99% | Rank 5 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 19.44% | 8.04% | Rank 84 |
| Earnings growth, 3 years per yeardoes not count towards the rank | – | 5.44% | |
| Earnings growth, 5 years per yeardoes not count towards the rank | – | 7.00% | |
| Sustainable growth (ROE × retained earnings) | 0.39% | 3.66% | Rank 7 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | −19.48% | 2.90% | Rank 0 |
| FCF yield | 12.16% | 3.63% | Rank 98 |
| EV/saleslower is better | 0.19 | 4.03 | Rank 98 |
| EV/EBITlower is betterdoes not count towards the rank | – | 21.73 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | 78.37% | 8.66% | Rank 96 |
| Share price, 6 months | 25.11% | 24.27% | Rank 51 |
| Share price, 3 months | 11.17% | 15.42% | Rank 37 |
| Distance from 52-week high | −8.25% | −7.35% | Rank 46 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | −15.26% | 0.30% | Rank 97 |
| Change in share countlower is better | −6.24% | 0.00% | Rank 98 |
| Dividend streak in years | – | 10 | Rank 13 |
| Price reaction to results, market-adjusted | 0.34% | 0.05% | Rank 51 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | 25.69% | 48.40% | Rank 14 |
| Net debt/EBITDAlower is better | −2.54 | 1.11 | Rank 93 |
| Debt to equitylower is better | 0.94 | 0.48 | Rank 24 |
| Volatility, 1 yearlower is better | 45.20% | 31.42% | Rank 16 |
Ten years in figures
| Year | Revenue, $B | EBIT margin | FCF | Shares | Net debt |
|---|---|---|---|---|---|
| 2016 | 40.6 | 3.1% | $1.5B | 328M | $725.0M |
| 2017 | 48.4 | 2.5% | $1.1B | 353M | $627.0M |
| 2018 | 60.1 | 2.4% | $559.0M | 399M | $1.3B |
| 2019 | 74.6 | 2.4% | $753.0M | 420M | $2.4B |
| 2020 | 111.1 | 2.8% | $4.6B | 579M | $7.5B |
| 2021 | 126.0 | 1.4% | $3.3B | 591M | $9.5B |
| 2022 | 144.5 | 0.9% | $5.3B | 582M | $9.3B |
| 2023 | 154.0 | 1.9% | $7.3B | 546M | $1.7B |
| 2024 | 163.1 | 2.0% | −$490.0M | 524M | $5.4B |
| 2025 | 194.8 | −3.9% | $4.3B | 491M | $889.0M |
3 of 7 StockScorer Score rules met · How the score is built
Centene Corp mainly meets criteria in the Valuation category. Result from 18 strategies checked.
Centene Corp is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
3 of 7 rules met
5 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for Centene Corp.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | −5.6 | 30.0 |
| P/B ratio | 1.7 | 4.8 |
| Return on equity (ROE) | −33.4% | 11.5% |
| Equity ratio | 25.7% | 48.4% |
| Debt-to-equity (D/E) | 0.94 | 0.48 |
| Dividend yield | 0.0% | 1.3% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| CNC | Centene Corpthis page | |
| HUM | Humana Inc | Low2.7 |
| CI | The Cigna Group | Low4.5 |
| ELV | Elevance Health Inc | Low3.6 |
| CVS | CVS Health Corp | locked |
| UNH | UnitedHealth Group Incorporated | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.